11 Hrs
Source:
وكالة الأنباء القطرية
Intestinal compound linked to cognitive decline
A study from the University of Wisconsin-Madison has revealed that the compound "Imidazole Propionate" (ImP), produced by certain types of gut bacteria, contributes to accelerating cognitive decline and increasing the risk of Alzheimer's disease. The research found that elevated levels of this compound, which is associated with impaired kidney filtration, coincide with the accumulation of "Beta-Amyloid" and "Tau" proteins in the brain—key hallmarks of the disease. Additionally, studies showed that genetic variations leading to higher "ImP" levels are present in about 43% of participants and are linked to an increased risk of Alzheimer's. The researchers believe that targeting this compound through the development of medications to lower its levels could help prevent the disease and slow mental deterioration.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)